Skip to main content

GLMD

Galmed Pharmaceuticals Ltd.

Company with tickers: GLMD

CIK
1595353
CUSIP
M47238148
Shares Outstanding
7,684,074
13F Activity (30d)
8 filings 8 filers

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 12
Total Value: $62,019
Total Shares: 126,582

Institutional Ownership Trend

7 quarters

Holder Concentration

Across 12 13F filers · Δ vs Dec 31, 2025
Top Holder
63.3%
Sep 2024 → Mar 2026 · range 44.2% – 94.0%
−2.2 pts
Top 5
100.0%
Sep 2024 → Mar 2026 · range 99.4% – 100.0%
+0.5 pts
Top 10
100.0%
Sep 2024 → Mar 2026 · range 100.0% – 100.0%
+0.0 pts
HHI
4,496
Sep 2024 → Mar 2026 · range 2,996 – 8,855
Highly concentrated−248

Quarterly Activity

vs Dec 31, 2025
New
1
Increased
1
Decreased
3
Sold Out
2
Unchanged
7
Holder count: -1
Institutional value: -51.7%
Shares held: -26.0%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 12 of 12
Export CSV
Holder Value (USD) % of 13F Shares Open